![](https://webarchive.library.unt.edu/eot2008/20090514052145im_/http://www.cancer.gov/images/spacer.gif) |
|
(oh-PREL-vuh-KIN)
![](https://webarchive.library.unt.edu/eot2008/20090514052145im_/http://www.cancer.gov/images/spacer.gif)
| A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. Oprelvekin is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called Neumega, recombinant human interleukin-11, and rhIL-11. |
Previous Definitions: | ophthalmoscope, opiate, opioid, opioid growth factor, opportunistic infection | Next Definitions: | OPT-80, optic chiasm, optic chiasma, optic nerve, optic pathway glioma |
|
![](https://webarchive.library.unt.edu/eot2008/20090514052145im_/http://www.cancer.gov/images/spacer.gif) |